These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Research and discussion on the evaluation scheme of reagent lot-to-lot differences in 16 chemiluminescence analytes, established by the EP26-A guidelines of the CLSI. Tao R; Zhang C; Liu M; Yang M; Gao W; Chen J; Mo N; Cheng Y; He J; Xie Q J Clin Lab Anal; 2021 Mar; 35(3):e23675. PubMed ID: 33274497 [TBL] [Abstract][Full Text] [Related]
9. Detecting reagent lot shifts using proficiency testing data. Tan RZ; Punyalack W; Graham P; Badrick T; Loh TP Pathology; 2019 Dec; 51(7):711-717. PubMed ID: 31607378 [TBL] [Abstract][Full Text] [Related]
10. Comparison between polynomial regression and weighted least squares regression analysis for verification of analytical measurement range. Jeong TD; Kim SK; Kim S; Lim CY; Chung JW Clin Chem Lab Med; 2022 Jun; 60(7):989-994. PubMed ID: 35531706 [TBL] [Abstract][Full Text] [Related]
11. Failure of internal quality control in detecting significant reagent lot shift in serum creatinine measurement. Chen X; Wang J; Zhang W; Xie E; Zhang B; Xu HG J Clin Lab Anal; 2019 Nov; 33(9):e22991. PubMed ID: 31373724 [TBL] [Abstract][Full Text] [Related]
12. A national surveillance program for evaluating new reagent lots in medical laboratories. Solsvik AE; Kristoffersen AH; Sandberg S; Gidske G; Stavelin AV; Eikeland J; Amundsen E Clin Chem Lab Med; 2022 Feb; 60(3):351-360. PubMed ID: 35073470 [TBL] [Abstract][Full Text] [Related]
13. Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice survey. Rutledge AC; Johnston A; Booth RA; Veljkovic K; Bailey D; Vandenberghe H; Waite G; Allen LC; Don-Wauchope A; Chan PC; Stemp J; Edmond P; Leung V; Aslan B Pract Lab Med; 2022 Nov; 32():e00300. PubMed ID: 36035320 [TBL] [Abstract][Full Text] [Related]
14. Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice. Cho MC; Kim SY; Jeong TD; Lee W; Chun S; Min WK Ann Clin Biochem; 2014 Nov; 51(Pt 6):688-94. PubMed ID: 24497612 [TBL] [Abstract][Full Text] [Related]
15. Lot-to-lot reagent verification: challenges and possible solutions. Loh TP; Sandberg S; Horvath AR Clin Chem Lab Med; 2022 Apr; 60(5):675-680. PubMed ID: 35191278 [TBL] [Abstract][Full Text] [Related]
16. Commutability limitations influence quality control results with different reagent lots. Miller WG; Erek A; Cunningham TD; Oladipo O; Scott MG; Johnson RE Clin Chem; 2011 Jan; 57(1):76-83. PubMed ID: 21097677 [TBL] [Abstract][Full Text] [Related]
17. The Importance of Reagent Lot Registration in External Quality Assurance/Proficiency Testing Schemes. Stavelin A; Riksheim BO; Christensen NG; Sandberg S Clin Chem; 2016 May; 62(5):708-15. PubMed ID: 26980211 [TBL] [Abstract][Full Text] [Related]
18. Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical chemistry data. Kim S; Chang J; Kim SK; Park S; Huh J; Jeong TD Clin Chem Lab Med; 2020 Jul; 59(1):127-138. PubMed ID: 32628625 [TBL] [Abstract][Full Text] [Related]
19. Analysis of reagent lot-to-lot comparability tests in five immunoassay items. Kim HS; Kang HJ; Whang DH; Lee SG; Park MJ; Park JY; Lee KM Ann Clin Lab Sci; 2012; 42(2):165-73. PubMed ID: 22585613 [TBL] [Abstract][Full Text] [Related]